GOLDMAN SACHS GROUP INC - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 84 filers reported holding AMRYT PHARMA PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.7%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q1 2023$2,390,653
+3174.9%
163,968
+1445.6%
0.00%
Q3 2022$73,000
-7.6%
10,609
-6.1%
0.00%
Q2 2022$79,000
-19.4%
11,293
-4.5%
0.00%
Q1 2022$98,000
-39.9%
11,826
-21.7%
0.00%
Q4 2021$163,000
-50.0%
15,110
-44.1%
0.00%
Q3 2021$326,00027,0210.00%
Other shareholders
AMRYT PHARMA PLC shareholders Q1 2023
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 8,857,268$61,912,00026.04%
Stonepine Capital Management, LLC 6,298,348$44,025,00020.48%
MPM ASSET MANAGEMENT LLC 2,668,843$18,655,0007.87%
Aquilo Capital Management, LLC 1,866,652$13,048,0004.45%
New Leaf Venture Partners, L.L.C. 449,737$3,144,0002.04%
Global Frontier Investments LLC 435,000$3,040,0001.42%
Rubric Capital Management LP 3,600,000$25,164,0001.32%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 6,333,552$44,272,0001.01%
Telemetry Investments, L.L.C. 121,670$850,0001.01%
Clearline Capital LP 631,942$4,417,0000.57%
View complete list of AMRYT PHARMA PLC shareholders